Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice-Reference-Cited by-同舟云学术

Low-level shRNA Cytotoxicity Can Contribute to MYC-induced Hepatocellular Carcinoma in Adult Mice

Published:2010-01 Issue:1 Volume:18 Page:161-170
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Beer Shelly,Bellovin David I,Lee Joyce S,Komatsubara Kimberly,Wang Lora S,Koh Huishan,Börner Kathleen,Storm Theresa A,Davis Corrine R,Kay Mark A,Felsher Dean W,Grimm Dirk

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference50 articles.

1. Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer;Calvisi;Toxicol Pathol,2005

2. Molecular pathogenesis of human hepatocellular carcinoma;Thorgeirsson;Nat Genet,2002

3. c-Myc target genes involved in cell growth, apoptosis, and metabolism;Dang;Mol Cell Biol,1999

4. Transient excess of MYC activity can elicit genomic instability and tumorigenesis;Felsher;Proc Natl Acad Sci USA,1999

5. The Myc/Max/Mad network and the transcriptional control of cell behavior;Grandori;Annu Rev Cell Dev Biol,2000

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-Myc;Cell & Bioscience;2024-03-23

2. Research Progress of Epigenetics in Liver Cancer;Journal of Cancer Therapy;2024

3. Molecular prospects of transcription activator-like effector nucleases (TALENs) in cancer management: Challenges and adaptations;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

4. VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy;Molecular Therapy - Nucleic Acids;2022-06

5. miRNAs in Lymphocytic Leukaemias—The miRror of Drug Resistance;International Journal of Molecular Sciences;2022-04-22